Trial Profile
The Effect of High-Dose Remifentanil on the Reversal of Established Capsaicin-Induced Hyperalgesia in Human Volunteers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Hyperalgesia
- Focus Therapeutic Use
- Acronyms RemiAnes 1
- 19 Nov 2016 Status changed from recruiting to completed.
- 15 Mar 2012 Actual initiation date 26 Jun 2009 added as reported by European Clinical Trials Database.
- 15 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.